Town Meeting on night #3 on April 7 started with a warning about inappropriate behavior not being tolerated (after the ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

The 2025 targets include achieving around €62 billion in revenues, falling costs in absolute terms, a stable cost of risk, ...

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...